Enovis Corporation
ENOV
$0.29 (-1.20%)
1D
1W
3M
1Y
5Y
ALL
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
GlobeNewsWire • 10 days ago • ENOV
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
Seeking Alpha • 20 days ago • ENOV
Enovis Corporation (ENOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
GlobeNewsWire • 25 days ago • ENOV
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewsWire • 27 days ago • ENOV
Enovis Appoints Oliver Engert as Chief Administrative Officer
Seeking Alpha • about 3 months ago • ENOV
Enovis Corporation (ENOV) Presents at UBS Global Healthcare Conference 2025 Transcript
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.